Related Experiment Video
Updated: Dec 21, 2025

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
Hypolipidemia is associated with the severity of COVID-19
Xiuqi Wei1, Wenjuan Zeng2, Jingyu Su1
1Department of Laboratory Medicine, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Insights
COVID-19 patients experienced lower lipid levels, including low-density lipoprotein cholesterol (LDL-c) and total cholesterol (TC). This hypolipidemia worsened with increasing disease severity, indicating a link between COVID-19 and lipid metabolism changes.
Area of Science:
- Medical Research
- Biochemistry
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is known to cause multiple organ dysfunctions.
- The impact of COVID-19 on patient lipid profiles, specifically dyslipidemia, remains largely uncharacterized.
Purpose of the Study:
- To investigate alterations in low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and total cholesterol (TC) in COVID-19 patients.
- To determine the relationship between these lipid profile changes and COVID-19 disease severity.
Main Methods:
- A retrospective study analyzed serum lipid levels (LDL-c, HDL-c, TC) in 597 hospitalized COVID-19 patients.
- Patients were categorized into mild, severe, and critical groups.
- A control group of 50 healthy individuals with matched age and gender was included for comparison.
Main Results:
- COVID-19 patients exhibited significantly lower LDL-c and TC levels compared to healthy controls.
- A progressive decrease in LDL-c and TC levels was observed across mild, severe, and critical COVID-19 cases.
- HDL-c levels significantly decreased only in critical COVID-19 cases.
- Lower lipid levels correlated inversely with C-reactive protein and interleukin-6, and positively with lymphocyte count.
Conclusions:
- Hypolipidemia, characterized by reduced lipid levels, is present even in mild COVID-19 cases.
- The severity of hypolipidemia in COVID-19 patients correlates with the overall severity of the disease.
Background:
Many patients with coronavirus disease 2019 (COVID-19) suffer multiple organ dysfunctions. However, whether patients develop dyslipidemia is unknown.
Objective:
In this study, we aimed to investigate the pathological alterations of low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and total cholesterol (TC) in COVID-19 patients and their relationships with the disease severity.
Methods:
A retrospective study was performed to examine serum levels of LDL-c, HDL-c, and TC on 597 COVID-19 patients (mild: 394; severe, 171; critical: 32) who were hospitalized in our center between February 1 and March 3, 2020. Age- and gender-matched normal subjects (n = 50) who had routine laboratory lipid tests between October 1 and November 1, 2019 in our center were included as the control group.
Results:
LDL-c and TC levels were significantly lower in COVID-19 patients as compared with normal subjects (P < .001). There were significant and gradual decreases in levels of LDL-c (median (IQR) in mg/dL, mild: 91 (76, 104); severe: 86 (69, 102); critical: 69 (48, 81); P < .02) and TC (mild: 173 (148, 203); severe: 167 (138, 197); critical: 125 (95, 162); P < .05) across all three groups. HDL-c levels only decreased significantly in critical cases as compared with levels in mild and severe cases. LDL-c and TC levels inversely correlated with C-reactive protein and interleukin-6, and positively correlated with the number of lymphocytes in patients.
Conclusions:
Development of hypolipidemia begins in patients with mild symptoms. It progressively becomes worse in an association with the disease severity.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Catabolism
